Drug Development 2
Course Level Undergraduate
Course Level Undergraduate
                                                        Area/Catalogue
                                                        
PHAR 3013
                                                    
                                                        Course Level
                                                        
Undergraduate
                                                    
                                                        Offered Externally
                                                        
No
                                                    
Course ID
101436
                                                        Unit Value
                                                        
4.5
                                                    
                                                        University-wide elective course
                                                        
No
                                                    
                                                        Course owner
                                                        
UniSA Clinical & Health Sciences
                                                    
To further extend prior knowledge of drug discovery in the critical evaluation of the major phases of the drug development process and apply this knowledge to the commercialisation aspects of a new drug program.
Intellectual property and patenting in the pharmaceutical industry; ownership of knowledge, ownership of information, IP protection. Clinical trials insight into industry. Diagnostics & Personalised medicine. Regulatory affairs; filing a New Drug Application (NDA); the evaluation of an NDA by the Food and Drug Administration and the Therapeutics Goods Administration. The use of data in drug development. Pharmaceutical commercialisation: how companies are funded; private and public funding of the pharmaceutical industry; spin-off and start-up companies; Ethical behaviour in pharmaceutical commercialisation; Role of pharmacoeconomics in strategic drug development.
Raymond G. Hill and Duncan B. Richards 2020, Drug Discovery and Development: Technology in Transition, Current, Churchill Livingstone (Elsevier)
| Common to all relevant programs | |
|---|---|
| Subject Area & Catalogue Number | Course Name | 
| PHAR 2009 | Drug Development 1 | 
Nil
| Component | Duration | ||
|---|---|---|---|
| INTERNAL, CITY WEST | |||
| Lecture | 2 hours x 13 weeks | ||
| Tutorial | 2 hours x 13 weeks | ||
Note: These components may or may not be scheduled in every study period. Please refer to the timetable for further details.
Presentation, Report, Test/Quiz
                EFTSL*: 0.125
                Commonwealth Supported program (Band 4C)
                To determine the fee for this course as part of a Commonwealth Supported program, go to:
                How to determine your Commonwealth Supported course fee. (Opens new window)
            
Fee-paying program for domestic and international students
International students and students undertaking this course as part of a postgraduate fee paying program must refer to the relevant program home page to determine the cost for undertaking this course.
Non-award enrolment
Non-award tuition fees are set by the university. To determine the cost of this course, go to:
How to determine the relevant non award tuition fee. (Opens new window)
Not all courses are available on all of the above bases, and students must check to ensure that they are permitted to enrol in a particular course.
* Equivalent Full Time Study Load. Please note: all EFTSL values are published and calculated at ten decimal places. Values are displayed to three decimal places for ease of interpretation.